Blaney McMurtry LLP
Blaney McMurtry LLP is a full-service law firm with expertise in the pharmaceutical, biologic, medical device, natural health products and cosmetic industries.
Our areas of expertise include:
INTELLECTUAL PROPERTY (IP)
• IP litigation, including pharmaceutical patent litigation and trademarks disputes;
• Patent, trademark and copyright protection and enforcement;
• Building and monetizing IP portfolios;
• Licensing, research and joint development agreements;
• Domain name protection and enforcement issues;
REGULATORY AND COMPLIANCE
• Health Canada submissions and review processes;
• Product recalls and detentions;
• Product liability and class actions;
• Pharmaceutical pricing and provincial formulary listing, including Patented Medicine Prices Review Board (PMPRB);
• Contesting decisions by regulatory authorities;
• Packaging, labelling, advertising and marketing issues;
• Clinical trial and quality agreements;
PRIVACY AND ACCESS TO INFORMATION
• Compliance with privacy legislation, including, requests under the Access to Information Act;
• Disclosure of clinical trial information;
• Privacy policies;
• Non-disclosure agreements;
CORPORATE AND COMMERCIAL SERVICES
• Incorporation, corporate governance, transactions, strategic tax planning, and financing;
• Contract manufacturing, research and co-development agreements;
• Joint ventures, partnership, mergers and corporate reorganizations;
• Corporate agreements, such as supply, distribution and product acquisition agreements; and
• Employment issues.
Related
Intrinsik Corp.
As a recognized leader in the industry, our team of experts provide regulatory and scientific advice to help you identify the most efficient drug development and registration...
September 19, 2025
Stelioz Solutions Inc.
Stelioz Solutions Inc. is a professional global consulting firm, serving medical device, natural health product, dietary supplement, food, beverage, cosmetic and veterinary...
November 11, 2025
VG SOLUTIONS INC.
• Product drug DIN, NHP NPN applications, notifications and amendments, Medical device site and product licenses, Drug Establishment and Site Licensing • Liaison – Health...
December 31, 2024

